Publications: Ms Bina Shah
Dimascio L, Hamborg T, Mihaylova B, Kassam J, Shah B, Stuart B, Griffin X
(
2024
)
.
ADHESIVE CAPSULITIS CORTICOSTEROID AND DILATION RANDOMISED CONTROLLED TRIAL: A FEASIBILITY STUDY IN PRIMARY CARE (ACCorD)
.
Bone & Joint Open
Di Mascio L, Hamborg T, Mihaylova B, Kassam J, Shah B, Stuart B, Griffin XL
(
2024
)
.
The Adhesive Capsulitis Corticosteroid and Dilation (ACCorD) randomized controlled trial
.
Bone & Joint Open
vol.
5
,
(
3
)
162
-
173
.
Grey ADR, Scott R, Shah B, Acher P, Liyanage S, Pavlou M, Omar R, Chinegwundoh F et al.
(
2022
)
.
Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study
.
The Lancet Oncology
vol.
23
,
(
3
)
428
-
438
.
Fabes J, Ambler G, Shah B, Williams NR, Martin D, Davidson BR, Spiro M
(
2021
)
.
Protocol for a prospective double-blind, randomised, placebo-controlled feasibility trial of octreotide infusion during liver transplantation
.
BMJ Open
vol.
11
,
(
12
)
Grey A, Scott R, Shah B, Acher P, Liyanage S, Pavlou M, Omar R, Chinegwundoh F et al.
(
2021
)
.
The CADMUS trial: A paired cohort, blinded study comparing multiparametric ultrasound targeted biopsies with multiparametric MRI targeted biopsies in the detection of clinically significant prostate cancer
.
Journal of Clinical Oncology
.
Conference:
not applicable
vol.
39
,
5008
-
5008
.
Grey ADR, Scott R, Shah B, Acher P, Liyanage S, Pavlou M, Omar R, Chinegwundoh F et al.
(
2021
)
.
The CADMUS trial: A paired cohort, blinded study comparing multiparametric ultrasound targeted biopsies with multiparametric MRI targeted biopsies in the detection of clinically significant prostate cancer
.
EUROPEAN UROLOGY
.
Conference:
EAU21 Virtual Congress
vol.
79
,
S1301
-
S1302
.
Grey A, Scott R, Charman S, van der Meulen J, Frinking P, Acher P, Liyanage S, Madaan S et al.
(
2017
)
.
The CADMUS trial – Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancer
.
Contemporary Clinical Trials
vol.
66
,
86
-
92
.